MY8800109A - Antipsychotic 5-fluoro-pyrimidin-2-yl piperazine compound - Google Patents
Antipsychotic 5-fluoro-pyrimidin-2-yl piperazine compoundInfo
- Publication number
- MY8800109A MY8800109A MY109/88A MY8800109A MY8800109A MY 8800109 A MY8800109 A MY 8800109A MY 109/88 A MY109/88 A MY 109/88A MY 8800109 A MY8800109 A MY 8800109A MY 8800109 A MY8800109 A MY 8800109A
- Authority
- MY
- Malaysia
- Prior art keywords
- antipsychotic
- pyrimidin
- fluoro
- piperazine compound
- piperazine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46427583A | 1983-02-07 | 1983-02-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY8800109A true MY8800109A (en) | 1988-12-31 |
Family
ID=23843239
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MY109/88A MY8800109A (en) | 1983-02-07 | 1988-12-30 | Antipsychotic 5-fluoro-pyrimidin-2-yl piperazine compound |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPS59148780A (sv) |
| DE (1) | DE3404193A1 (sv) |
| FR (1) | FR2540499B1 (sv) |
| GB (1) | GB2139217B (sv) |
| MY (1) | MY8800109A (sv) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4748240A (en) * | 1987-04-03 | 1988-05-31 | American Home Products Corporation | Psychotropic bicyclic imides |
| US5239847A (en) * | 1991-06-12 | 1993-08-31 | Samsung Electronics Co., Ltd. | Agitator for a washing machine |
| US5631017A (en) * | 1993-03-26 | 1997-05-20 | Beth Israel Deaconess Medical Center, Inc. | Topical application of buspirone for treatment of pathological conditions associated with immune responses |
| US5484788A (en) * | 1993-03-26 | 1996-01-16 | Beth Israel Hospital Association | Buspirone as a systemic immunosuppressant |
| US5637314A (en) * | 1995-06-07 | 1997-06-10 | Beth Israel Deaconess Medical Center, Inc. | Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3398151A (en) * | 1966-02-01 | 1968-08-20 | Mead Johnson & Co | Azaspirodecanediones and azaspiroundecanediones |
| BE759371A (fr) * | 1969-11-24 | 1971-05-24 | Bristol Myers Co | Azaspirodecanediones heterocycliques et procedes pour leur preparation |
| US3976776A (en) * | 1972-12-06 | 1976-08-24 | Mead Johnson & Company | Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones |
| US4182763A (en) * | 1978-05-22 | 1980-01-08 | Mead Johnson & Company | Buspirone anti-anxiety method |
-
1984
- 1984-02-06 JP JP59018502A patent/JPS59148780A/ja active Granted
- 1984-02-06 FR FR8401751A patent/FR2540499B1/fr not_active Expired
- 1984-02-06 GB GB08403102A patent/GB2139217B/en not_active Expired
- 1984-02-07 DE DE19843404193 patent/DE3404193A1/de active Granted
-
1988
- 1988-12-30 MY MY109/88A patent/MY8800109A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB2139217A (en) | 1984-11-07 |
| DE3404193A1 (de) | 1984-08-09 |
| JPS59148780A (ja) | 1984-08-25 |
| DE3404193C2 (sv) | 1987-06-11 |
| FR2540499A1 (fr) | 1984-08-10 |
| GB2139217B (en) | 1986-07-09 |
| GB8403102D0 (en) | 1984-03-07 |
| FR2540499B1 (fr) | 1986-09-26 |
| JPH0319233B2 (sv) | 1991-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2146333B (en) | Piperazine derivatives | |
| GB2114122B (en) | Piperazine derivatives | |
| GB2163432B (en) | Piperazine derivatives | |
| GB2116967B (en) | Piperazine derivatives | |
| ZA851486B (en) | Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives | |
| GB2157685B (en) | Piperazine derivatives | |
| ZA825479B (en) | Thiazolidinylalkylene piperazine derivatives | |
| GB2114121B (en) | Piperazine derivatives | |
| GB2135991B (en) | Piperazine derivatives | |
| GB2143235B (en) | 1-pyridyl-alkyl-4-aryl piperazine derivatives | |
| GB2120670B (en) | Piperazine derivatives | |
| GB8301678D0 (en) | Heterocyclic compounds | |
| GB2131016B (en) | Piperazine derivatives | |
| GB2139217B (en) | Antipsychotic 5-fluoro-pyrimidin-2-yl piperazine compound | |
| GB2105714B (en) | Spirothiazolidinyl piperazine derivatives | |
| GB2162843B (en) | Piperazine derivatives | |
| ZA823777B (en) | Piperazine derivatives | |
| GB8303782D0 (en) | Heterocyclic compounds | |
| GB2143523B (en) | Heterocyclic compounds | |
| GB8314244D0 (en) | Piperazine derivatives | |
| IE831502L (en) | Piperazine derivatives | |
| IE831387L (en) | Piperazine derivatives | |
| GB8304528D0 (en) | Piperazine derivatives | |
| DE3566257D1 (en) | Piperazine derivatives | |
| IE812092L (en) | Piperazine derivatives |